from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1766/-

LFCtreatmentdescriptionclass of inhibitor

0.447

Amikacinug/mL Amikacintranslation

1.221

Cap5-10ug/mL Capreomycintranslation

2.233

Rox10-50 ug/mL Roxithromycintranslation

1.065

SM2-5 ug/mL Streptomycintranslation

1.230

Tet5-10 ug/mL Tetracyclinetranslation

0.058

Rif0.2-5ug/mL Rifampicintranscription

0.069

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.039

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.191

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.085

CPZ10-50 ug/mL Chlorpromazinerespiration

1.372

Clofazimine10-13 ug/mL Clofaziminerespiration

1.026

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.117

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.457

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.428

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.687

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.031

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.156

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.194

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.679

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.365

KCN5-20 ug/mL Potassium cyaniderespiration

-1.020

NaN30.2-2 mM Sodium aziderespiration

-1.726

Nigericin50 uM Nigericinrespiration

0.507

TRC10-150 ug/mL Triclosanrespiration

0.174

TRZ10-25 ug/mL Thioridazinerespiration

-0.927

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.620

menadione6-10 ug/mL Menadionerespiration

0.254

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.262

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.137

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.693

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.384

NRP_1Non-replicating persistence stage 1dosRassociated

0.051

Amp0.2mg/mL AmpicillincellWall

-0.150

Cephalexin20-100 ug/mL CephalexincellWall

0.489

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.220

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.199

EMB10-20 ug/mL EthambutolcellWall

0.489

Eta12-40 ug/mL EthionamidecellWall

0.612

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.186

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-2.384

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.424

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.293

BZA0.12 mg/mL BenzamidearomaticAmides

-0.570

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.171

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.367

H2O24 mM hydrogen peroxideDNAdamaging

-0.026

Levo10 ug/mL LevofloxacinDNAdamaging

-0.403

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.875

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.118

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.438

UVUV-irradiationDNAdamaging

-1.585

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.097

Antimycin12.5-50 ug/mL Antimycin A?

-1.105

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.348

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.104

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.538

PA8240.2-2 ug/mL PA-824?

0.245

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.283

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.956

Verapamil50 uM Verapamil?

-0.739

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.308

methoxatin10-20 ug/mL Methoxatin?